查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
磷脂市場 - 增長、趨勢、COVID-19 影響和預測（2022-2027 年）
市場調查報告書
商品編碼
1136087

磷脂市場 - 增長、趨勢、COVID-19 影響和預測（2022-2027 年）

Phospholipids Market - Growth, Trends, and Forecasts (2022 - 2027)
出版日期: | 出版商: Mordor Intelligence | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計在 2022-2027 年的預測期內，磷脂市場的複合年增長率為 5.6%。

由於磷脂的多功能性，食品、補充劑和藥品等各個行業對磷脂的需求不斷增加。此外，豐富的原材料使製造商能夠利用資源並擴大其產品組合。例如，2021 年，新西蘭恆天然合作集團有限公司將推出 NZMP 牛奶磷脂 70，品牌名稱為 NZMP。這種磷脂成分適用於各種食品和飲料產品，包括補充香囊、營養棒和即食保健粉，以在大流行期間放大的壓力挑戰下增強情緒和認知能力。

然後，由於對天然保健品的需求不斷增加，磷脂成為營養保健品中一種很有前途的天然成分。此外，健康生活方式的日益普及，加上功能性食品和便利店消費的增加，進一步增加了對磷脂原料的需求，推動了預測期內的市場增長。

磷脂由於其乳化特性而被廣泛用於食品和糖果中。嬰兒配方奶粉也是磷脂應用增長最快的領域，因為它富含對嬰兒營養至關重要的 DHA、ALA 和歐米茄脂肪酸。這些特性將對全球市場的磷脂原料產生積極影響。

主要市場趨勢

在營養素和補充劑中的使用範圍擴大

由於全球消費者對營養保健品的消費量不斷增加，保健品行業對磷脂的需求也在增加。磷脂□絲氨酸主要用於大腦健康補充劑，因為它有助於改善認知功能。此外，最近的研究表明，服用磷脂□絲氨酸補充劑可能有益於患有註意力缺陷多動障礙的兒童和患有焦慮和壓力的年輕人。此外，磷脂□絲氨酸因其健康益處而被廣泛用於運動營養產品中，例如提高運動表現、促進疲勞恢復和防止肌肉酸痛。同樣，磷脂□膽鹼也被廣泛用於嬰兒配方奶粉，因為它富含二十二碳六烯酸和花生四烯酸，這對嬰兒的生長至關重要。正因為如此，人群對基於磷脂的膳食補充劑的需求不斷增加，進一步推動了磷脂原料市場的增長。

亞太地區正在蓬勃發展

由於各種應用行業的需求不斷增加，預計亞太地區將成為磷脂市場增長最快的地區。由於食品和飲料製造業的高需求，中國在磷脂市場佔有最大份額。此外，大豆、向日葵、雞蛋、油菜籽和牛奶等原材料的豐富供應鼓勵小型企業生產用於食品和保健品配方的天然原料。印度見證了以磷脂為基礎的營養和健康補充劑的高采用率，因為它對健康有益，包括吸收 omega-3 脂肪酸，這反過來又推動了對磷脂的需求。

此外，製造商正在研發創新的磷脂配方，以應對新興的最終用途細分市場，例如功能性食品。例如，2020 年 11 月，恆天然推出了一系列新的牛奶磷脂，包括用於功能性食品和飲料的 NZMP 牛奶磷脂，以管理壓力的影響。隨後，越來越多的年輕人口和不斷增強的健康意識促使消費者尋求更好的替代品，例如食品補充劑。因此，它正在增加亞太地區磷脂的市場價值。此外，製藥行業的持續擴張有望在未來幾年為磷脂供應商提供有利可圖的機會。

競爭格局

全球磷脂市場正在整合，開發營養成分的主要公司希望將業務擴展到食品、飲料、營養保健品和製藥行業。 Cargill Inc.、Lipoid、Lecico GmbH、VAV 生命科學和 Novastell Ingredients Essentials 等公司在這個市場上運營。由於 FDA 法規的普遍性，大公司佔據了上風並繼續主導市場。該地區的主要公司將併購作為加強其產品組合、為更廣泛的客戶提供服務並擴展到未開發市場的戰略。例如，2019 年，油和配料解決方案製造商 Avril Group 收購了磷脂製造商 Lecico GmbH，以擴大其在德國的業務。

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法

第 3 章執行摘要

第 4 章市場動態

  • 市場驅動力
  • 市場製約因素
  • 波特五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分

  • 按類型
    • 磷脂□絲氨酸
    • 磷脂□膽鹼
    • 其他
  • 按供應來源
    • 大豆
    • 向日葵
    • 雞蛋
    • 其他
  • 按用途
    • 食物和飲料
    • 營養補充劑
    • 藥品
    • 其他
  • 區域信息
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
      • 北美其他地區
    • 歐洲
      • 英國
      • 德國
      • 西班牙
      • 法國
      • 意大利
      • 俄羅斯
      • 其他歐洲
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 其他亞太地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲
    • 中東和非洲
      • 沙特阿拉伯
      • 南非
      • 其他中東

第 6 章競爭格局

  • 最常採用的策略
  • 市場份額分析
  • 公司簡介
    • Cargill Inc
    • Kewpie Corporation
    • Lasenor
    • Lipoid GmbH
    • Lecico gmbh
    • VAV life science
    • Novastell Ingredients Essentials
    • ECA Healthcare Inc.
    • Croda International Plc
    • CHEMI S.P.A.

第 7 章市場機會和未來趨勢

第 8 章 COVID-19 對市場的影響

第9章免責聲明

簡介目錄
Product Code: 92025

The Phospholipids market is projected to register a CAGR of 5.6% during the forecast period, 2022-2027.

The demand for phospholipids has been increasing in various industries including food, supplements, and pharmaceutical owing to their versatile property. In addition, the abundant availability of raw materials had enabled the manufacturers to utilize the resource and expand their product portfolio. For instance, in 2021, Fonterra Co-Operative Group Limited, the New Zealand company launched NZMP milk phospholipid 70 under the brand name NZMP. This phospholipid ingredient is suitable for various food and beverage products including supplement sachets, nutritional bars, and ready-to-mix health powders, and is specially formulated for mood enhancement and cognitive performance under stress issues that have been amplified during the pandemic period.

Subsequently, phospholipid is a promising natural ingredient for nutritional supplements products owing to the increasing demand for natural health supplements. In addition, the growing adoption of a healthy lifestyle coupled with increasing consumption of functional and convenience foods are further increasing the demand for phospholipid ingredients which in turn drives the market growth in the forecast period.

Owing to its emulsifying property, phospholipid has wide application in the food and confectionery industry. In addition, infant formula is the fastest growing application segment for phospholipids as it is rich in DHA, ALA, and omega fatty acids which are essential components for infant nutrition. This attribute will impact positively the phospholipid ingredients in the global market.

Key Market Trends

Increasing utilization in nutrients and supplements

The demand for phospholipids is increasing in the nutraceutical industry owing to the rising consumption of nutritional supplements among global consumers. Phosphatidylserine is majorly used in brain health supplements as it helps to boost cognitive function. Moreover, recent studies indicate that the consumption of phosphatidylserine supplements might act beneficial to children with attention deficit hyperactivity disorder and the young population suffering from anxiety and stress. In addition, Phosphatidylserine is widely utilized in sports nutrition products owing to its health benefits such as improving sports performance, speeding up recovery, and preventing muscle soreness. Similarly, Phosphatidylcholine is widely used in infant formula as it is enriched with docosahexaenoic acid and arachidonic acid which is essential for infant growth. Thereby, the increasing demand for phospholipid-based nutritional supplements among the population is further boosting the growth of the phospholipids ingredients market.

Asia-Pacific is the Fastest Growing Region

The Asia-Pacific region is anticipated to be the fastest-growing region for the phospholipids market due to its increasing demand in various application industries. China holds the largest share in the phospholipid market owing to its high demand in food and beverage manufacturing. Further, the abundant availability of raw materials such as soy, sunflower, egg, rapeseed, and milk is encouraging the small-scale players to produce naturally sourced ingredients for food and nutraceutical formulation. India has witnessed a higher adoption rate of phospholipid-based nutritional and health supplements due to its health benefits including the absorption of omega-3 fatty acids, which in turn, drives the demand for phospholipids.

Moreover, the manufacturers are engaged in formulating innovative phospholipids to cater to emerging end-use segments such as functional food products. For instance, in November 2020, Fonterra launched a new range of milk phospholipids including NZMP milk phospholipids for functional food & beverages to manage the effect of stress. Subsequently, the growing young population coupled with raising health consciousness has driven consumers to look up better alternatives such as food supplements. As a result, it strengthens the market value of phospholipids in the Asia-Pacific region. Additionally, the ongoing expansion of the pharmaceutical industry is anticipated to offer lucrative opportunities for phospholipid suppliers in the coming years.

Competitive Landscape

The global phospholipids market is consolidated as major players are coming up with nutritional ingredients in order to expand their reach in the food, beverage, nutraceuticals, and pharmaceutical industries. The players such as Cargill Inc., Lipoid, Lecico GmbH, VAV life science, and Novastell Ingredients Essentials among others are operating in the market. With prevalent FDA regulations, the leading players have an upper edge and continue to dominate the market. Major players in the region have been focusing on mergers and acquisitions as a strategy to strengthen their product portfolio, to cater a wide range of customers, and expand to untapped markets. For instance, in 2019, Avril Group, a manufacturer of oil and ingredient solutions acquired Lecico GmbH, a producer of phospholipids to expand their business activities in Germany.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Drivers
  • 4.2 Market Restraints
  • 4.3 Porter's Five Force Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Bargaining Power of Buyers/Consumers
    • 4.3.3 Bargaining Power of Suppliers
    • 4.3.4 Threat of Substitute Products
    • 4.3.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Phosphotidylserine
    • 5.1.2 Phosphotidylcholine
    • 5.1.3 Others
  • 5.2 By Source
    • 5.2.1 Soy
    • 5.2.2 Sunflower
    • 5.2.3 Egg
    • 5.2.4 Others
  • 5.3 By Application
    • 5.3.1 Food & beverage
    • 5.3.2 Nutraceutical Supplements
    • 5.3.3 Pharmaceuticals
    • 5.3.4 Others
  • 5.4 By Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
      • 5.4.1.4 Rest of North America
    • 5.4.2 Europe
      • 5.4.2.1 United Kingdom
      • 5.4.2.2 Germany
      • 5.4.2.3 Spain
      • 5.4.2.4 France
      • 5.4.2.5 Italy
      • 5.4.2.6 Russia
      • 5.4.2.7 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 Rest of Asia-Pacific
    • 5.4.4 South America
      • 5.4.4.1 Brazil
      • 5.4.4.2 Argentina
      • 5.4.4.3 Rest of South America
    • 5.4.5 Middle East & Africa
      • 5.4.5.1 Saudi Arabia
      • 5.4.5.2 South Africa
      • 5.4.5.3 Rest of Middle East & Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Most Adopted Strategies
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles
    • 6.3.1 Cargill Inc
    • 6.3.2 Kewpie Corporation
    • 6.3.3 Lasenor
    • 6.3.4 Lipoid GmbH
    • 6.3.5 Lecico gmbh
    • 6.3.6 VAV life science
    • 6.3.7 Novastell Ingredients Essentials
    • 6.3.8 ECA Healthcare Inc.
    • 6.3.9 Croda International Plc
    • 6.3.10 CHEMI S.P.A.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

8 IMPACT OF COVID-19 ON THE MARKET

9 DISCLAIMER